Does immune tolerance decrece in pregnancy
Reading File
Finding Sources
Searching PubMed
immune tolerance pregnancy maternal fetal
Finding Sources
Reading Article
PMID: 38724467
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from authoritative sources. Let me compile the full answer:
Immune Tolerance in Pregnancy: Does It Decrease?
No - immune tolerance does not decrease in pregnancy. It actually increases locally and is actively remodeled systemically. The short answer to the question is the opposite of what is often assumed. Pregnancy involves a sophisticated immune shift rather than global suppression.
The Core Concept
Pregnancy presents a unique immunological paradox: the fetus carries paternal alloantigens (foreign HLA molecules) that, in any other context, would trigger immune rejection. Yet the fetus is normally tolerated for ~40 weeks. This happens through active, coordinated mechanisms that enhance tolerance at the maternal-fetal interface while selectively modulating (not abolishing) systemic immunity.
As stated in Creasy & Resnik's Maternal-Fetal Medicine (p. 192), the pregnant maternal innate immune system is "not indifferent to the fetus," but animal depletion studies have shown the immune cells at the implantation site actually support - rather than reject - the fetus.
Mechanisms That INCREASE Tolerance in Pregnancy
1. HLA Antigen Remodeling on Trophoblast
- Villous trophoblast (in contact with maternal blood) is class I MHC-negative - it does not display HLA-A or HLA-B, making it immunologically invisible to circulating T cells.
- Extravillous cytotrophoblast (invading the decidua) expresses HLA-C, HLA-E, HLA-F, and HLA-G - non-classical, low-polymorphism molecules that dampen NK cell and T cell killing.
- HLA-E and HLA-G interact with killer immunoglobulin receptors (KIRs) on uterine NK cells, inhibiting their cytotoxic function while promoting cytokine secretion. (Creasy & Resnik, p. 188-189)
2. Expansion of Regulatory T Cells (Tregs)
- Tregs are substantially increased at the implantation site and throughout gestation.
- They suppress alloreactive T cells directed against paternal antigens.
- The PD-1/PD-L1 checkpoint pathway promotes Treg development and function while simultaneously inhibiting TH17 pro-inflammatory cells.
- Deficiencies in Tregs are associated with early pregnancy loss. (Creasy & Resnik, p. 189, 191)
3. Decidual NK Cells (dNK) - Unique Phenotype
- 70-80% of decidual leukocytes in the first trimester are NK cells, but they are functionally distinct from peripheral NK cells.
- Decidual NK cells are CD56bright / CD16dim (not the usual CD56dim/CD16bright peripheral type), with poor cytotoxicity but strong cytokine-secreting function.
- They actively support vascular remodeling and placentation rather than attacking the fetus. (Berek & Novak's Gynecology, p. 1808)
4. Apoptosis of Alloreactive T Cells (Fas/FasL System)
- Trophoblast cells highly express FasL (Fas ligand) at the decidual surface.
- When maternal T cells that recognize paternal antigens approach, FasL triggers apoptosis in those Fas-receptor-expressing T cells - effectively deleting the cells most likely to attack the fetus. (Creasy & Resnik, p. 189)
5. IDO (Indoleamine 2,3-Dioxygenase)
- IDO produced at the maternal-fetal interface degrades tryptophan, an amino acid essential for T cell proliferation.
- Tryptophan depletion starves alloreactive T cells, suppressing their activity locally.
6. Cytokine Shift: Th1 → Th2
- Pregnancy shifts the systemic balance from Th1 (cell-mediated, pro-inflammatory) toward Th2 (humoral, anti-inflammatory) responses.
- Th2 cytokines (IL-4, IL-5, IL-10, IL-13) dominate and promote tolerance to the allograft fetus.
- Th1-driven autoimmune diseases (e.g., rheumatoid arthritis, multiple sclerosis) often improve during pregnancy, while Th2-driven diseases (e.g., systemic lupus, asthma) may worsen - reflecting this shift.
What IS Reduced in Pregnancy (the "Decreased Immunity" Part)
While local fetal tolerance increases, cell-mediated (Th1) immunity is selectively downregulated systemically. From Murray & Nadel's Textbook of Respiratory Medicine (p. 2138):
"A woman's immune system changes during pregnancy to allow tolerance to paternally derived fetal antigens. This involves predominantly a down-regulation of cell-mediated immunity, balanced by an up-regulated humoral immune response. The pregnant woman is therefore at risk of more severe manifestations of certain infections, particularly viral and fungal infections."
This is why pregnant women have:
- Greater severity with influenza, varicella, COVID-19, listeria, coccidioidomycosis
- Increased risk from intracellular pathogens (which require Th1/cell-mediated responses to clear)
- Improved tolerance of the fetus (the purpose of the shift)
Clinical Consequences of This Immune Remodeling
| Aspect | Effect |
|---|---|
| Fetal tolerance | Increased (the whole point) |
| Th1-mediated autoimmune disease (RA, MS) | Often improves in pregnancy |
| Th2-mediated disease (SLE, asthma) | May worsen |
| Viral/fungal infections | More severe due to Th1 suppression |
| Postpartum period | Immune tolerance wanes → autoimmune flares common (e.g., postpartum thyroiditis) |
The Wang et al. 2024 review in the Chinese Medical Journal summarizes this as maternal-fetal tolerance being established through a "sophisticated crosstalk" between extravillous trophoblast cells, decidual immune cells, and decidual stromal cells - and that failures in this crosstalk underlie recurrent spontaneous abortion, preeclampsia, and preterm birth.
Summary
Immune tolerance in pregnancy does not decrease - it increases locally at the maternal-fetal interface through multiple overlapping mechanisms (HLA remodeling, Tregs, dNK cells, FasL-mediated apoptosis, IDO, Th2 shift). What does decrease is cell-mediated (Th1) immunity, which makes pregnant women more vulnerable to certain infections. These two phenomena serve the same master purpose: protecting the fetus from immune rejection.
Sources: Creasy & Resnik's Maternal-Fetal Medicine, pp. 188-192 | Berek & Novak's Gynecology, p. 1808 | Murray & Nadel's Respiratory Medicine, p. 2138 | Wang et al., Chin Med J, 2024
Factors influence outcome of pregnancy in a woman with ckd
Reading File
Finding Sources
Searching PubMed
chronic kidney disease pregnancy outcomes factors
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, high-quality data from three dedicated nephrology/obstetric textbook sections. Let me compose the full answer.
Factors Influencing Pregnancy Outcome in Women with CKD
Pregnancy in CKD carries risks for both mother and fetus that increase with disease severity. Three key prepregnancy factors are the main predictors of pregnancy outcomes - and in most circumstances they are more important than the specific kidney disease etiology:
- Degree of reduction in GFR / elevation in serum creatinine
- Presence and severity of coexisting hypertension
- Amount of proteinuria
(Comprehensive Clinical Nephrology, 7th Ed., p. 754)
1. Baseline Renal Function (CKD Stage / Serum Creatinine)
This is the single most powerful predictor. Risks increase in parallel with worsening CKD stage:
| Serum Creatinine at Conception | Preterm Delivery Rate | Key Complications |
|---|---|---|
| < 1.4 mg/dL (mild, CKD 1-2) | ~20% | 10% preeclampsia, 24% SGA |
| ≥ 1.4 mg/dL (moderate, CKD 3) | ~59% | High preeclampsia + FGR |
| ≥ 2.5 mg/dL (severe, CKD 4-5) | up to 86% | Very high risk of indicated preterm delivery |
Even CKD stages 1 and 2 carry higher rates of preeclampsia, perinatal mortality, preterm delivery, and SGA compared to the general population. Superimposed preeclampsia can occur even when preconception creatinine is only slightly elevated (0.9-1.4 mg/dL).
(Creasy & Resnik's Maternal-Fetal Medicine, p. 1375-1376)
2. Hypertension
Preexisting hypertension independently doubles the risk for severe neonatal outcomes (early preterm delivery, NICU admission, SGA). In women with CKD stages 3+, chronic hypertension is the strongest predictor of:
- Preterm delivery before 34 weeks
- Greater decline in maternal kidney function during and after pregnancy
Absence of an early fall in serum creatinine (which should normally occur due to physiologic hyperfiltration in pregnancy) is itself a warning sign of impending preterm delivery and kidney function loss.
(Comprehensive Clinical Nephrology, p. 771-772, 1033)
3. Proteinuria
- Women with CKD stages 3-5 and a urine protein:creatinine ratio > 100 mg/mmol (> 0.9 mg/mg) before pregnancy or before 20 weeks are more than twice as likely to deliver an SGA baby.
- The combination of preconception GFR < 40 mL/min/1.73 m² and proteinuria > 1 g/day strongly predicts postpartum GFR decline - more so than either factor alone.
(Comprehensive Clinical Nephrology, p. 778, 1033)
4. Underlying Cause of CKD
While GFR, hypertension, and proteinuria dominate, certain etiologies carry disease-specific risks:
Diabetic Kidney Disease
- Preexisting vascular disease impairs placental development.
- Impaired autonomic function reduces hemodynamic adaptation to pregnancy.
- Additional risks from poor glycemic control: fetal malformations, macrosomia, polyhydramnios.
- Requires intensive preconception optimization of HbA1c, BP, and proteinuria (RAAS blockade before conception, stopped at confirmed pregnancy).
Lupus Nephritis
- Pregnancy-related immunologic/hormonal changes can precipitate flares.
- Predictors of poor outcome: active kidney disease, reduced GFR, hypocomplementemia, antiphospholipid antibodies.
- Preeclampsia is frequent and often clinically indistinguishable from a lupus nephritis flare.
- Recommend ≥ 6 months of disease remission before conception.
IgA Nephropathy
- Generally better outcomes than other CKD causes, comparable to CKD stage-matched women.
- Still carries increased risk: preeclampsia (OR 4.29), preterm birth (OR 2.69), SGA (OR 1.84).
- Pregnancy does not accelerate kidney dysfunction in CKD stage 1-2.
(NKF Primer on Kidney Diseases, 8th Ed., p. 495; Comprehensive Clinical Nephrology, p. 1044-1046)
5. Advanced Maternal Age and Comorbidities
The NKF Primer explicitly lists advanced maternal age, diabetes, hypertension, and use of assisted reproductive technologies as factors increasing risk independently of CKD stage.
(NKF Primer on Kidney Diseases, 8th Ed., p. 494)
6. Dialysis Status
Women on dialysis have the worst outcomes among CKD patients. Live birth rates are severalfold lower than the general population (5.8 vs. 61.9 live births/1000 women/year in Australia/New Zealand). Pregnancy on dialysis requires intensive dialysis (often daily/nocturnal), strict fluid and electrolyte control, and erythropoietin therapy for anaemia.
7. Effect of Pregnancy on Maternal Kidney Function (Bidirectional Risk)
This is a critical factor to counsel women about:
| CKD Stage at Conception | Risk of Kidney Function Decline |
|---|---|
| Stage 1-2 (non-lupus) | Low; long-term prognosis generally unaltered if BP controlled and proteinuria minimal |
| Stage 3 | 16% progress to a more advanced stage; pregnancy equates to 1.7-2.1 years of added kidney disease progression |
| Stage 4-5 | 20% may require kidney replacement within 6 months postpartum; pregnancy equates to ~4.9 years of added progression |
50% of women with serum creatinine > 1.5 mg/dL will have a significant rise in creatinine in the third trimester or early postpartum. Postpartum deterioration can be unpredictable even when antenatal function was stable - surveillance must continue after delivery.
(Comprehensive Clinical Nephrology, p. 1033; NKF Primer, p. 494)
Summary Table
| Factor | Impact on Outcome |
|---|---|
| CKD stage / baseline creatinine | Higher stage = more preterm birth, preeclampsia, SGA, ESRD progression |
| Hypertension | Strongest predictor of preterm delivery < 34 wks and GFR decline |
| Proteinuria > 1 g/day | > 2x risk of SGA; combined with low GFR, predicts maternal decline |
| Underlying cause (lupus, DKD) | Lupus flare risk; DKD vascular disease; antiphospholipid Abs |
| Dialysis status | Very high risk; lowest live birth rates |
| Advanced maternal age / ART | Additional independent risk |
| Preconception optimization | Well-controlled BP + minimal proteinuria = significantly improved outcomes |
The most important clinical message: women with CKD who enter pregnancy with well-controlled blood pressure, treated proteinuria, and stable kidney function can achieve excellent outcomes - making preconception care the single most modifiable intervention.
Sources: Creasy & Resnik's Maternal-Fetal Medicine, pp. 1375-1377 | Comprehensive Clinical Nephrology 7th Ed., pp. 754-780, 1029-1037 | NKF Primer on Kidney Diseases 8th Ed., pp. 494-495 | Smith et al., Nat Rev Nephrol, 2025
This is a shared conversation. Sign in to Orris to start your own chat.